Korean Market
EXCH
GemVax & KAEL
★

GemVax & KAEL Largest Shareholder Amends Pledge Contract, Slight Debt Reduction and Extension but Pledge Risk Remains High

 
EXCH
GemVax & KAEL
★★★★

GemVax Largest Shareholder Gem&Company Partially Repays Stock-Backed Loan and Adds More Pledged Shares, Total Pledged Reaches 5.45 Million Shares... Risk of Equity Stake Dropping to 0.01% if Pledges Exercised

 
EXCH
GemVax & KAEL
★★★

GemVax's Largest Shareholder Gem&Company Pledges 5.23M Shares, Risking Ownership Drop from 12.32% to 0.51%, Dilution and Control Change Concerns

 
OWNR
GemVax & KAEL
★

GemVax & KAEL Non-Registered Chairman Nam Gyeong-pil Acquires 55,348 Shares, Minimal Dilution Impact

 
OWNR
GemVax & KAEL
★

Gem & Company Slightly Increases Stake in GemVax via Special Relation Addition and Voting Rights Delegation, Extends Pledge Agreements

 
EXCH
GemVax & KAEL
★★★★

Largest Shareholder Gem&Company Pledges 95.85% of Stake, Secures 7.7 Trillion Won in Loans for Operations, Raising Severe Governance and Financial Risks

 
EXCH
GemVax & KAEL
★

GemVax to Hold IR Event on June 17 2026 Sharing Business Progress and Vision

 
OWNR
GemVax & KAEL
★

Gem & Company Increases Pledge on GemVax Shares Signaling Financial Strain - Impact on Shareholder Value

 
EXCH
GemVax & KAEL
★★★

Largest Shareholder Gem & Company Expands Pledged Shares to 5.23 Million; Stake Could Plummet to 0.51% If All Executed, Risking Loss of Control

 
EXCH
GemVax & KAEL
★★★★

Major Shareholder's Pledge Expansion Intensifies Dilution and Control Change Risk

 
EXCH
GemVax & KAEL
★★★★

Largest Shareholder Gem&Company Increases Pledged Shares to 5.16M; Risk of Stake Collapse to 0.66% upon Enforcement

 
EXCH
GemVax & KAEL
★

GemVax Completes 7 Billion Won Premium Convertible Bond Issuance: Secures R&D Funding While Dilution Risk Persists

 
MATR
GemVax & KAEL
★

Decision to issue KRW 7 billion premium convertible bonds (conversion price KRW 18,659, +12% vs market)

 
MATR
GemVax & KAEL
★

17 billion won 3rd-party allotment, offering price 26,470 won (premium over current price)

 
EXCH
GemVax & KAEL
★★★

Additional Pledge by Largest Shareholder Risks Stake Drop to 0.87% if All Pledges Executed